Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered

被引：8
|
作者：
Deltenre, Pierre [1 ,2 ]
Moreno, Christophe [1 ,3 ]
Trepo, Eric [1 ,3 ]
机构：
[1] Univ Libre Bruxelles, CUB Hop Erasme, Dept Gastroenterol Hepatopancreatol & Digest Onco, Brussels, Belgium
[2] Clin St Luc, Dept Gastroenterol & Hepatol, Bouge, Belgium
[3] Univ Libre Bruxelles, Lab Expt Gastroenterol, Brussels, Belgium
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷 / 04期
关键词：
SCLEROSING CHOLANGITIS;
D O I：
10.1016/j.jhep.2021.02.036
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：989 / 990
页数：2
相关论文
共 50 条
  • [1] Reply to: "Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered"
    Mallet, Vincent
    JOURNAL OF HEPATOLOGY, 2021, 75 (04) : 990 - 992
  • [2] Intravenous ketamine and progressive cholangiopathy in COVID-19 patients
    Mallet, Vincent
    Bock, Kilian
    Mandengue, Paul Doumbe
    Dufour, Nicolas
    Voigtlaender, Torsten
    Ricard, Jean-Damien
    Isnard, Pierre
    Frochot, Vincent
    Letavernier, Emmanuel
    Moga, Lucile
    Landrieux, Amandine
    Rautou, Pierre-Emmanuel
    Pons-Kerjean, Nathalie
    Vallet-Pichard, Anais
    Chouchana, Laurent
    Gernez, Coralie
    Burger, Carole
    Scemla, Anne
    de Tymoski, Christian
    Depret, Francois
    Dudoignon, Emmanuel
    Lamhaut, Lionel
    Flicoteau, Remi
    Rousseau, Geraldine
    Van Huyen, Jean-Paul Duong
    Correas, Jean-Michel
    Wedemeyer, Heiner
    Pol, Stanislas
    JOURNAL OF HEPATOLOGY, 2021, 74 (05) : 1243 - 1244
  • [3] Intravenous ketamine and progressive cholangiopathy in covid-19 patients
    Bock, Kilian
    Wedemeyer, Heiner
    Mallet, Vincent
    JOURNAL OF HEPATOLOGY, 2021, 75 : S438 - S438
  • [4] Ketamine-induced cholangiopathy in ARDS patients
    Christian de Tymowski
    François Dépret
    Emmanuel Dudoignon
    Matthieu Legrand
    Vincent Mallet
    Intensive Care Medicine, 2021, 47 : 1173 - 1174
  • [5] Ketamine-induced cholangiopathy in ARDS patients
    de Tymowski, Christian
    Depret, Francois
    Dudoignon, Emmanuel
    Legrand, Matthieu
    Mallet, Vincent
    INTENSIVE CARE MEDICINE, 2021, 47 (10) : 1173 - 1174
  • [6] Cholangiopathy in Early Rehabilitation After Intensive Care Treatment of Patients With COVID-19
    Linneweber, Lutz
    Mann, Alexander Bernd
    Denk, Gerald
    Kraft, Eduard
    Weber, Sabine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (01): : 196 - 198
  • [7] COVID-19 Vaccination-Induced Cholangiopathy and Autoimmune Hepatitis: A Series of Two Cases
    Zafar, Mansoor
    Gordon, Katherine
    Macken, Lucia
    Parvin, Joe
    Heath, Simon
    Whibley, Max
    Tibble, Jeremy
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [8] SHOULD STATINS BE CONSIDERED FOR TREATMENT OF COVID-19 PATIENTS?
    Javed, Muhammad Ali
    Alsaei, Ahmed
    Onyambu, Steve
    Mateen, Pamir
    Khan, Azam
    Sadaka, Farid
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 88 - 88
  • [9] Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient With COVID-19
    Knooihuizen, Sally A. I.
    Aday, Ariel
    Lee, William M.
    HEPATOLOGY, 2021, 74 (01) : 519 - 521
  • [10] Early detection of COVID-19 cholangiopathy using cholangioscopy—a case report of two critically ill patients
    Veronika Kroepfl
    Benedikt Treml
    Martin Cornelius Freund
    Christoph Profanter
    European Surgery, 2022, 54 : 326 - 330
12345